Antibodies targeting S protein aim to neutralize mammalian host-cell interaction, thereby minimizing viral multiplicity of infection, however, recent studies have shown that “antibodies are not enough” to protect against COVID-19 for a variety of reasons, including S-protein glycosylation, which shields the antibody from eliciting an optimal neutralization response (2). The gene discussed is PROS1; the disease is COVID-19.